Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

These medications for BPH have known risks and may have new side effects.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5α-Reductase inhibitors don't cause depression.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Raltegravir may cause hair loss in some patients.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.